Search - tctmd.com

Displaying 961 - 980 of 4573

Sort: Relevancy | Date

Presentation TCT 2015

Rationale for and Design of HORIZONS-ABSORB

Presenter: Dariusz Dudek, Robert J. de Winter, Gregg W. Stone

October 11, 2015

Presentation TCT 2015

Restenosis and Stent Thrombosis

Presenter: George D. Dangas, Ehrin J. Armstrong

October 11, 2015

Presentation TCT 2015

Five-Year Results From the EXAMINATION Trial

Presenter: Dariusz Dudek, Robert J. de Winter, Manel Sabate

October 11, 2015

Presentation TCT 2015

Debate: Should Prasugrel and Ticagrelor Be Used in a Substantial Number of Patients With Stable CAD? No, the Risks Are Real and There Is No Evidence for Benefit!

Presenter: John A. Bittl, E. Magnus Ohman, Jorge F. Saucedo

October 11, 2015

Presentation TCT 2015

Outcomes After Contemporary DES in STEMI: Glass Half Full or Half Empty?

Presenter: Dariusz Dudek, Robert J. de Winter, Tullio Palmerini

October 11, 2015

Presentation TCT 2015

Debate: Should Prasugrel and Ticagrelor Be Used in a Substantial Number of Patients With Stable CAD? Yes, the Benefits Outweigh the Risks!

Presenter: John A. Bittl, E. Magnus Ohman, Christoph A. Kaiser

October 11, 2015

Presentation TCT 2015

Bioresorbable Scaffolds in STEMI: Rationale and 1-Year TROFI II Results

Presenter: Dariusz Dudek, Robert J. de Winter, Patrick W. Serruys

October 11, 2015

Presentation TCT 2015

Specialized Stents in STEMI: MGuard From MASTER I to MASTER II

Presenter: Dariusz Dudek, Robert J. de Winter, Gregg W. Stone

October 11, 2015

Presentation TCT 2015

Featured Lecture: Should Stent Design Impact DAPT Duration Decisions? Insights From the DAPT Study

Presenter: John A. Bittl, E. Magnus Ohman, James B. Hermiller Jr

October 11, 2015

Presentation TCT 2015

Has the Case for Radial Intervention in STEMI Been Proven Beyond Doubt? The Case for and Against (an Internal Debate)

Presenter: Dariusz Dudek, Robert J. de Winter, Ajay J. Kirtane

October 11, 2015

Presentation TCT 2015

Featured Lecture: New DAPT Duration Recommendations

Presenter: John A. Bittl, E. Magnus Ohman

October 11, 2015

Presentation TCT 2015

Is the Debate Over? Routine Thrombus Aspiration in STEMI (From TAPAS to INFUSE-AMI to TASTE to TOTAL)

Presenter: Dariusz Dudek, Robert J. de Winter, Stefan K. James

October 11, 2015

Presentation TCT 2015

Debate: The Case for Long-term DAPT After Stenting In Most Patients!

Presenter: Regina Deible, Daniel I. Simon

October 11, 2015

Presentation TCT 2015

Lessons From the TAXUS Liberté/Prasugrel Substudy

Presenter: John A. Bittl, E. Magnus Ohman, David P. Lee

October 11, 2015

Presentation TCT 2015

Bare-Metal and Drug-Eluting Stents: Devices, Indications, and Outcomes

Presenter: Emmanouil S. Brilakis, Rajesh V Swaminathan

October 11, 2015

Presentation TCT 2015

Debate: What Is the Ideal Duration of DAPT After DES? Shorter Is Best (for Most)!

Presenter: John A. Bittl, E. Magnus Ohman, Hyeon-Cheol Gwon

October 11, 2015

Presentation TCT 2015

Biomimetic Stents: Rationale and Current Clinical Results

Presenter: Prakash Krishnan, Mahmood K. Razavi, Eric J. Dippel

October 11, 2015

Presentation TCT 2015

Debate: What Is the Ideal Duration of DAPT After DES? Longer Is Better (for Most)!

Presenter: John A. Bittl, E. Magnus Ohman, David P. Lee

October 11, 2015

Presentation TCT 2015

What Have We Learned From All-Comers Head-to-Head DES Trials II? The COMPARE Trials

Presenter: Stephen G. Ellis, John A. Ormiston, Pieter C. Smits

October 11, 2015

Presentation TCT 2015

What Have We Learned From All-Comers Head-to-Head DES Trials I? The SORT OUT Trial

Presenter: Stephen G. Ellis, John A. Ormiston, Evald H. Christiansen

October 11, 2015

Advertisement

Rationale for and Design of HORIZONS-ABSORB

Restenosis and Stent Thrombosis

Five-Year Results From the EXAMINATION Trial

Debate: Should Prasugrel and Ticagrelor Be Used in a Substantial Number of Patients With Stable CAD? No, the Risks Are Real and There Is No Evidence for Benefit!

Outcomes After Contemporary DES in STEMI: Glass Half Full or Half Empty?

Debate: Should Prasugrel and Ticagrelor Be Used in a Substantial Number of Patients With Stable CAD? Yes, the Benefits Outweigh the Risks!

Bioresorbable Scaffolds in STEMI: Rationale and 1-Year TROFI II Results

Specialized Stents in STEMI: MGuard From MASTER I to MASTER II

Featured Lecture: Should Stent Design Impact DAPT Duration Decisions? Insights From the DAPT Study

Has the Case for Radial Intervention in STEMI Been Proven Beyond Doubt? The Case for and Against (an Internal Debate)

Featured Lecture: New DAPT Duration Recommendations

Is the Debate Over? Routine Thrombus Aspiration in STEMI (From TAPAS to INFUSE-AMI to TASTE to TOTAL)

Debate: The Case for Long-term DAPT After Stenting In Most Patients!

Lessons From the TAXUS Liberté/Prasugrel Substudy

Bare-Metal and Drug-Eluting Stents: Devices, Indications, and Outcomes

Debate: What Is the Ideal Duration of DAPT After DES? Shorter Is Best (for Most)!

Biomimetic Stents: Rationale and Current Clinical Results

Debate: What Is the Ideal Duration of DAPT After DES? Longer Is Better (for Most)!

What Have We Learned From All-Comers Head-to-Head DES Trials II? The COMPARE Trials

What Have We Learned From All-Comers Head-to-Head DES Trials I? The SORT OUT Trial

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content